{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:26:35Z","timestamp":1789608395600,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T00:00:00Z","timestamp":1385424000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1245\/s10434-013-3407-6","type":"journal-article","created":{"date-parts":[[2013,11,25]],"date-time":"2013-11-25T15:50:13Z","timestamp":1385394613000},"page":"908-914","source":"Crossref","is-referenced-by-count":27,"title":["Melphalan: A Promising Agent in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy"],"prefix":"10.1245","volume":"21","author":[{"given":"Armando","family":"Sardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Nieroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Sittig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suven","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim","family":"Gushchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,26]]},"reference":[{"issue":"1","key":"3407_CR1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/(SICI)1096-9098(199901)70:1<6::AID-JSO2>3.0.CO;2-X","volume":"70","author":"GH Eltabbakh","year":"1999","unstructured":"Eltabbakh GH, Piver MS, Hempling RE, Recio FO, Intengen ME. Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma. J Surg Oncol. 1999;70(1):6\u201312.","journal-title":"J Surg Oncol."},{"issue":"39","key":"3407_CR2","doi-asserted-by":"crossref","first-page":"5489","DOI":"10.3748\/wjg.v18.i39.5489","volume":"18","author":"YL Klaver","year":"2012","unstructured":"Klaver YL, Lemmens VE, Nienhuijs SW, Luyer MD, de Hingh IH. Peritoneal carcinomatosis of colorectal origin: incidence, prognosis and treatment options. World J Gastroenterol. 2012;18(39):5489\u201394.","journal-title":"World J Gastroenterol."},{"issue":"6","key":"3407_CR3","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.surg.2013.01.001","volume":"153","author":"HR Alexander Jr","year":"2013","unstructured":"Alexander HR Jr, Bartlett DL, Pingpank JF, et al. Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma. Surgery. 2013;153(6):779\u201386.","journal-title":"Surgery."},{"issue":"25","key":"3407_CR4","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.2174\/138161212802002616","volume":"18","author":"S Mulier","year":"2012","unstructured":"Mulier S, Claes JP, Dierieck V, et al. Survival benefit of adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the different time-points of treatment of ovarian cancer: review of evidence. Curr Pharm Des. 2012;18(25):3793\u2013803.","journal-title":"Curr Pharm Des."},{"issue":"6","key":"3407_CR5","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.hoc.2012.08.010","volume":"26","author":"S Shankar","year":"2012","unstructured":"Shankar S, Ledakis P, El Halabi H, Gushchin V, Sardi A. Neoplasms of the appendix: current treatment guidelines. Hematol Oncol Clin North Am. 2012;26(6):1261\u201390.","journal-title":"Hematol Oncol Clin North Am."},{"issue":"3","key":"3407_CR6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/PPO.0b013e3181a9c781","volume":"15","author":"PH Sugarbaker","year":"2009","unstructured":"Sugarbaker PH. Epithelial appendiceal neoplasms. Cancer J. 2009;15(3):225\u201335.","journal-title":"Cancer J."},{"issue":"1","key":"3407_CR7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2174\/157016309787581084","volume":"6","author":"K Speeten Van der","year":"2009","unstructured":"Van der Speeten K, Stuart OA, Sugarbaker PH. Using pharmacologic data to plan clinical treatments for patients with peritoneal surface malignancy. Curr Drug Discov Technol. 2009;6(1):72\u201381.","journal-title":"Curr Drug Discov Technol."},{"issue":"7","key":"3407_CR8","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/jnci\/89.7.480","volume":"89","author":"RL Dedrick","year":"1997","unstructured":"Dedrick RL, Flessner MF. Pharmacokinetic problems in peritoneal drug administration: tissue penetration and surface exposure. J Natl Cancer Inst. 1997;89(7):480\u20137.","journal-title":"J Natl Cancer Inst."},{"key":"3407_CR9","volume-title":"Technical handbook for the integration of cytoreductive surgery and perioperative intraperitoneal chemotherapy into the surgical management of gastrointestinal and gynecologic malignancy","author":"PH Sugarbaker","year":"2005","unstructured":"Sugarbaker PH. Technical handbook for the integration of cytoreductive surgery and perioperative intraperitoneal chemotherapy into the surgical management of gastrointestinal and gynecologic malignancy. 4th ed. Grand Rapids (MI): The Ludann Company, 2005.","edition":"4"},{"issue":"2","key":"3407_CR10","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/01.sla.0000152015.76731.1f","volume":"241","author":"TJ Miner","year":"2005","unstructured":"Miner TJ, Shia J, Jaques DP, Klimstra DS, Brennan MF, Coit DG. Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg. 2005;241(2):300\u20138.","journal-title":"Ann Surg."},{"issue":"8","key":"3407_CR11","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1245\/s10434-007-9410-z","volume":"14","author":"L Bijelic","year":"2007","unstructured":"Bijelic L, Yan TD, Sugarbaker PH. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. Ann Surg Oncol. 2007;14(8):2281\u20138.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"3407_CR12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1245\/s10434-006-9174-x","volume":"14","author":"RM Smeenk","year":"2007","unstructured":"Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA. Progression of pseudomyxoma peritonei after combined modality treatment: management and outcome. Ann Surg Oncol. 2007;14(2):493\u20139.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"3407_CR13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ejso.2012.12.018","volume":"39","author":"A Bhangu","year":"2013","unstructured":"Bhangu A, Broom L, Nepogodiev D, Gourevitch D, Desai A. Outcomes of isolated limb perfusion in the treatment of extremity soft tissue sarcoma: a systematic review. Eur J Surg Oncol. 2013;39(4):311\u20139.","journal-title":"Eur J Surg Oncol."},{"issue":"2","key":"3407_CR14","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jamcollsurg.2011.03.013","volume":"213","author":"AK Raymond","year":"2011","unstructured":"Raymond AK, Beasley GM, Broadwater G, et al. Current trends in regional therapy for melanoma: lessons learned from 225 regional chemotherapy treatments between 1995 and 2010 at a single institution. J Am Coll Surg. 2011;213(2):306\u201316.","journal-title":"J Am Coll Surg."},{"issue":"4","key":"3407_CR15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/jso.22029","volume":"104","author":"A Testori","year":"2011","unstructured":"Testori A, Verhoef C, Kroon HM, Pennacchioli E, Faries MB, Eggermont AM, Thompson JF. Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion. J Surg Oncol. 2011;104(4):397\u2013404.","journal-title":"J Surg Oncol."},{"issue":"4","key":"3407_CR16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/02656730210123534","volume":"18","author":"M Urano","year":"2002","unstructured":"Urano M, Ling CC. Thermal enhancement of melphalan and oxaliplatin cytotoxicity in vitro. Int J Hyperthermia. 2002;18(4):307\u201315.","journal-title":"Int J Hyperthermia."},{"issue":"2","key":"3407_CR17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00280-006-0238-1","volume":"59","author":"PH Sugarbaker","year":"2007","unstructured":"Sugarbaker PH, Stuart OA. Pharmacokinetic and phase II study of heated intraoperative intraperitoneal melphalan. Cancer Chemother Pharmacol. 2007;59(2):151\u20135.","journal-title":"Cancer Chemother Pharmacol."},{"issue":"6","key":"3407_CR18","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00280-006-0229-2","volume":"58","author":"F Mohamed","year":"2006","unstructured":"Mohamed F, Stuart OA, Glehen O, Urano M, Sugarbaker PH. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor. Cancer Chemother Pharmacol. 2006;58(6):719\u201324.","journal-title":"Cancer Chemother Pharmacol."},{"issue":"1","key":"3407_CR19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00280-004-0779-0","volume":"54","author":"O Glehen","year":"2004","unstructured":"Glehen O, Stuart OA, Mohamed F, Sugarbaker PH. Hyperthermia modifies pharmacokinetics and tissue distribution of intraperitoneal melphalan in a rat model. Cancer Chemother Pharmacol. 2004;54(1):79\u201384.","journal-title":"Cancer Chemother Pharmacol."},{"key":"3407_CR20","first-page":"827534","volume":"2012","author":"L Bijelic","year":"2012","unstructured":"Bijelic L, Sugarbaker PH, Stuarte O. Hyperthermic intraperitoneal chemotherapy with melphalan: a summary of clinical and pharmacological data in 34 patients. Gastroenterol Res and Pract. 2012;2012:827534.","journal-title":"Gastroenterol Res and Pract."},{"issue":"6","key":"3407_CR21","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S1072-7515(00)00253-2","volume":"190","author":"SR Pestieau","year":"2000","unstructured":"Pestieau SR, Jelinek JS, Chang D, Jacquet P, Sugarbaker PH. CT in the selection of patients with abdominal or pelvic sarcoma for reoperative surgery. J Am Coll Surg. 2000;190(6):700\u201310.","journal-title":"J Am Coll Surg."},{"key":"3407_CR22","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/00000478-199512000-00006","volume":"19","author":"BM Ronnett","year":"1995","unstructured":"Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis: a clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to \u201cpseudomyxoma peritonei\u201d. Am J Surg Pathol. 1995;19:1390\u2013408.","journal-title":"Am J Surg Pathol."},{"issue":"1","key":"3407_CR23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/1097-0142(20010701)92:1<85::AID-CNCR1295>3.0.CO;2-R","volume":"92","author":"BM Ronnett","year":"2001","unstructured":"Ronnett BM, Yan H, Kurman RJ, Shmookler BM, Wu L, Sugarbaker PH. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer 2001;92(1):85\u201391.","journal-title":"Cancer"},{"issue":"4","key":"3407_CR24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/jso.21053","volume":"98","author":"J Esquivel","year":"2008","unstructured":"Esquivel J, Elias D, Baratti D, Kusamura S, Deraco M. Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination. J Surg Oncol. 2008;98(4):263\u20137.","journal-title":"J Surg Oncol."},{"issue":"8","key":"3407_CR25","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s10434-001-0632-1","volume":"8","author":"SL Blair","year":"2001","unstructured":"Blair SL, Chu DZ, Schwarz RE. Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer. Ann Surg Oncol. 2001;8(8):632\u20137.","journal-title":"Ann Surg Oncol."},{"issue":"4","key":"3407_CR26","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1245\/s10434-006-9303-6","volume":"14","author":"LK Helyer","year":"2007","unstructured":"Helyer LK, Law CH, Butler M, Last LD, Smith AJ, Wright FC. Surgery as a bridge to palliative chemotherapy in patients with malignant bowel obstruction from colorectal cancer. Ann Surg Oncol. 2007;14(4):1264\u201371.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"3407_CR27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/jso.20736","volume":"96","author":"TD Yan","year":"2007","unstructured":"Yan TD, Zappa L, Edwards G, Alderman R, Marquardt CE, Sugarbaker PH. Perioperative outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy for non-appendiceal peritoneal carcinomatosis from a prospective database. J Surg Oncol. 2007;96(2):102\u201312.","journal-title":"J Surg Oncol."},{"issue":"3","key":"3407_CR28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","volume":"30","author":"J Franko","year":"2012","unstructured":"Franko J, Shi Q, Goldman CD, et al. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol. 2012;30(3):263\u20137.","journal-title":"J Clin Oncol."},{"issue":"4","key":"3407_CR29","first-page":"309","volume":"67","author":"NA Newman","year":"2012","unstructured":"Newman NA, Votanopoulos KL, Stewart JH, Shen P, Levine EA. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer. Minerva Chir. 2012;67(4):309\u201318.","journal-title":"Minerva Chir."},{"issue":"3","key":"3407_CR30","first-page":"400","volume":"16","author":"JD Spiliotis","year":"2011","unstructured":"Spiliotis JD, Halkia EA, Efstathiou E. Peritoneal carcinomatosis 2011; it\u2019s about time for chemosurgery. J BUON. 2011;16(3):400\u20138.","journal-title":"J BUON."},{"issue":"1","key":"3407_CR31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.7326\/0003-4819-101-1-14","volume":"101","author":"SB Howell","year":"1984","unstructured":"Howell SB, Pfeifle CE, Olshen RA. Intraperitoneal chemotherapy with melphalan. Ann Intern Med. 1984;101(1):14\u20138.","journal-title":"Ann Intern Med."},{"issue":"2","key":"3407_CR32","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1634\/theoncologist.10-2-112","volume":"10","author":"PH Sugarbaker","year":"2005","unstructured":"Sugarbaker PH, Mora JT, Carmignani P, Stuart OA, Yoo D. Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy. Oncologist. 2005;10(2):112\u201322.","journal-title":"Oncologist."},{"issue":"1","key":"3407_CR33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/156802612798919187","volume":"12","author":"CL Defty","year":"2012","unstructured":"Defty CL, Marsden JR. Melphalan in regional chemotherapy for locally recurrent metastatic melanoma. Curr Top Med Chem. 2012;12(1):53\u201360.","journal-title":"Curr Top Med Chem."},{"issue":"1","key":"3407_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/02656736.2012.740548","volume":"29","author":"NA Vohra","year":"2013","unstructured":"Vohra NA, Turaga KK, Gonzalez RJ, et al. The use of isolated limb infusion in limb threatening extremity sarcomas. Int J Hyperthermia. 2013;29(1):1\u20137.","journal-title":"Int J Hyperthermia."},{"issue":"3","key":"3407_CR35","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1524-4725.2011.01883.x","volume":"37","author":"NC Zeitouni","year":"2011","unstructured":"Zeitouni NC, Giordano CN, Kane JM 3rd. In-transit Merkel cell carcinoma treated with isolated limb perfusion or isolated limb infusion: a case series of 12 patients. Dermatol Surg. 2011;37(3):357\u201364.","journal-title":"Dermatol Surg."},{"issue":"1","key":"3407_CR36","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1245\/s10434-011-1903-0","volume":"19","author":"HE Halabi","year":"2012","unstructured":"Halabi HE, Gushchin V, Francis J, et al. Prognostic significance of lymph node metastases in patients with high-grade appendiceal cancer. Ann Surg Oncol. 2012;19(1):122\u20135.","journal-title":"Ann Surg Oncol."},{"issue":"1","key":"3407_CR37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221(1):29\u201342.","journal-title":"Ann Surg."},{"issue":"3","key":"3407_CR38","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jamcollsurg.2009.04.019","volume":"209","author":"C Omohwo","year":"2009","unstructured":"Omohwo C, Nieroda CA, Gushchin V, et al. Complete cytoreduction offers longterm survival in patients with paritoneal carcinomatosis from appendiceal tumors of unfavorable histology. American College of Surgeons. J Am Coll Surg. 2009;209(3):308\u201312.","journal-title":"J Am Coll Surg."},{"issue":"1","key":"3407_CR39","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1245\/s10434-011-1840-y","volume":"19","author":"H Halabi El","year":"2012","unstructured":"El Halabi H, Gushchin V, MacDonald R, et al. The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS\/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis. Ann Surg Oncol. 2012;19(1):110\u20134.","journal-title":"Ann Surg Oncol."},{"key":"3407_CR40","doi-asserted-by":"crossref","unstructured":"Van Sweringen HL, Hanseman DJ, Ahmad SA, Edwards MJ, Sussman JJ. Predictors of survival in patients with high-grade peritoneal metastases undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Surgery. 2012;152(4):617\u201324, discussion 624\u20135.","DOI":"10.1016\/j.surg.2012.07.027"},{"issue":"2","key":"3407_CR41","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.cyto.2012.01.012","volume":"58","author":"SL Rellick","year":"2012","unstructured":"Rellick SL, Piktel D, Walton C, et al. Melphalan exposure induces an interleukin-6 deficit in bone marrow stromal cells and osteoblasts. Cytokine. 2012;58(2):245\u201352.","journal-title":"Cytokine."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-013-3407-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-013-3407-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-013-3407-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T11:23:11Z","timestamp":1559647391000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-013-3407-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,26]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["3407"],"URL":"https:\/\/doi.org\/10.1245\/s10434-013-3407-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,26]]}}}